Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2019
Historique:
received: 26 06 2018
accepted: 02 09 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 26 12 2019
Statut: epublish

Résumé

The diagnosis of Lassa fever is crucial to confirm cases, as well as to control/prevent nosocomial and community-based transmission and initiation of treatment, which is still limited in the country. Thus, we aimed at providing some information on the laboratory detection of Lassa from suspected cases in Nigeria. This was a retrospective study of seasonal Lassa fever outbreaks data from 1,263 samples analyzed using Reverse Transcription-Polymerase Chain Reaction (RT-PCR) at the Virology Research Laboratory, College of Medicine, University of Lagos/Lagos University Teaching Hospital between year 2011 and 2017. Data were analyzed using the 21 The RT-PCR test confirmed the presence of Lassa in 112 (8.9%) comprising 61 (54.4%) males, 48 (42.9%) females and 3 (2.7%) individuals without gender information. Those aged between 18 and 49 years were mostly affected. There was a decline in the detection of Lassa from 4.7% in 2011/2012 to less than 1% by the 2014/2015. However, during the 2015/2016 and 2016/2017 seasons the detection rates increased to 10.4% and 15.1% respectively. The Northern region of Nigeria reported high confirmed cases of Lassa. The South Western region also witnessed an increased Lassa fever positivity rate of 13.4% of which Lagos and Ogun states being the focal state of Lassa activity in the region. These established the need for heightening the continued surveillance for Lassa as well as the establishment of other testing facilities within these endemic regions for prompt diagnosis of Lassa fever.

Identifiants

pubmed: 31819792
doi: 10.11604/pamj.2019.34.76.16425
pii: PAMJ-34-76
pmc: PMC6884721
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Informations de copyright

© Salu Olumuyiwa Babalola et al.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Emerg Infect Dis. 2005 Oct;11(10):1642-4
pubmed: 16355508
J Vector Borne Dis. 2007 Mar;44(1):1-11
pubmed: 17378212
Emerg Infect Dis. 2006 May;12(5):835-7
pubmed: 16704848
Emerg Infect Dis. 2015 Apr;21(4):609-18
pubmed: 25811712
Biochem Syst Ecol. 2001 Jan 1;29(1):21-30
pubmed: 11068121
BMJ. 2003 Nov 29;327(7426):1271-5
pubmed: 14644972
Viruses. 2012 Oct 09;4(10):2031-48
pubmed: 23202452
Emerg Infect Dis. 2010 Oct;16(10):1598-600
pubmed: 20875288
Clin Infect Dis. 2010 Dec 15;51(12):1435-41
pubmed: 21058912
BMC Public Health. 2012 Nov 21;12:1014
pubmed: 23170851
Zoonoses Public Health. 2012 Sep;59 Suppl 2:43-7
pubmed: 22958249
Pathog Glob Health. 2017 Sep;111(6):276-288
pubmed: 28875769
J Clin Microbiol. 2017 Jun;55(6):1629-1637
pubmed: 28404674
Virol J. 2011 Oct 24;8:478
pubmed: 22023795
Emerg Infect Dis. 2010 Jun;16(6):1040-1
pubmed: 20507773
Bull World Health Organ. 1975;52(4-6):523-34
pubmed: 821625
Crit Rev Clin Lab Sci. 2004;41(4):339-90
pubmed: 15487592
Science. 1974 Jul 19;185(4147):263-5
pubmed: 4833828
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
Clin Infect Dis. 2003 May 15;36(10):1254-8
pubmed: 12746770
Environ Health Perspect. 2004 Jul;112(10):1092-8
pubmed: 15238283
J Infect Dis. 1987 Mar;155(3):445-55
pubmed: 3805772
Am J Trop Med Hyg. 1996 Dec;55(6):661-6
pubmed: 9025695
Disaster Mil Med. 2016 Apr 30;2:8
pubmed: 28265442
Afr J Lab Med. 2016 Oct 17;5(1):468
pubmed: 28879118
MMWR Morb Mortal Wkly Rep. 2004 Oct 1;53(38):894-7
pubmed: 15457145
Sci Rep. 2016 May 03;6:25280
pubmed: 27140942

Auteurs

Salu Olumuyiwa Babalola (SO)

Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos (CMUL), PM.B. 12003, Lagos, Nigeria.
Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

James Ayorinde Babatunde (JA)

Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.
Department of Biochemistry, College of Medicine, University of Lagos, PM.B. 12003, Lagos, Nigeria.

Orenolu Mercy Remilekun (OM)

Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

Anyanwu Roosevelt Amaobichukwu (AR)

Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

Abdullah Mariam Abiodun (AM)

Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

Idris Jide (I)

Honourable Commissioner for Health, Lagos State Ministry of Health, Alausa, Ikeja, Lagos, Nigeria.

Abdus-Salam Ismail Adeshina (AI)

Epidemiology Unit, Directorate of Disease Control, Lagos State Ministry of Health, Alausa, Ikeja, Lagos, Nigeria.

Ihekweazu Chikwe (I)

Nigerian Centre for Disease Control (NCDC), Plot 801, Ebitu Ukiwe Street, Jabi, Abuja, Nigeria.

Omilabu Sunday Aremu (OS)

Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos (CMUL), PM.B. 12003, Lagos, Nigeria.
Centre for Human and Zoonotic Virology (CHAZVY), Central Research Laboratory, College of Medicine, University of Lagos (CMUL)/Lagos University Teaching Hospital (LUTH), Lagos, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH